The Live Biotherapeutics Market is driven by the growing focus on microbiome-based therapies for treating chronic diseases, ...

These factors collectively contribute to the optimistic outlook for Passage Bio, justifying the Buy rating given by Yun Zhong. Based on the recent corporate insider activity of 10 insiders ...